These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 32160017)

  • 1. Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.
    Prasla Z; Sutliff RL; Sadikot RT
    Am J Respir Cell Mol Biol; 2020 Aug; 63(2):144-151. PubMed ID: 32160017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontuberculous mycobacteria infections in immunosuppressed hosts.
    Henkle E; Winthrop KL
    Clin Chest Med; 2015 Mar; 36(1):91-9. PubMed ID: 25676522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
    Yoon HJ; Choi HY; Ki M
    BMC Infect Dis; 2017 Jun; 17(1):432. PubMed ID: 28619015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.
    Prevots DR; Marras TK
    Clin Chest Med; 2015 Mar; 36(1):13-34. PubMed ID: 25676516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of nontuberculous mycobacteria by gaseous ozone treatment.
    Misawa K; Nishimura T; Kashimura S; Hasegawa N
    J Infect Chemother; 2023 Jun; 29(6):628-630. PubMed ID: 36894014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.
    Manika K; Tsikrika S; Tsaroucha E; Karabela S; Karachaliou I; Bosmi I; Kioumis I; Papavasileiou A
    Future Microbiol; 2015; 10(8):1301-6. PubMed ID: 26226382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
    Dahl VN; Mølhave M; Fløe A; van Ingen J; Schön T; Lillebaek T; Andersen AB; Wejse C
    Int J Infect Dis; 2022 Dec; 125():120-131. PubMed ID: 36244600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
    Kendall BA; Winthrop KL
    Semin Respir Crit Care Med; 2013 Feb; 34(1):87-94. PubMed ID: 23460008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 12. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 13. Nontuberculous Mycobacteria-Overview.
    Koh WJ
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28128073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients.
    Koh WJ; Kwon OJ; Lee KS
    Korean J Radiol; 2002; 3(3):145-57. PubMed ID: 12271159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease.
    Honda JR; Knight V; Chan ED
    Clin Chest Med; 2015 Mar; 36(1):1-11. PubMed ID: 25676515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial clustering of pulmonary nontuberculous mycobacterial disease.
    Colombo RE; Hill SC; Claypool RJ; Holland SM; Olivier KN
    Chest; 2010 Mar; 137(3):629-34. PubMed ID: 19858235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan - a Retrospective, Five-Year Multicenter Study.
    Huang HL; Cheng MH; Lu PL; Shu CC; Wang JY; Wang JT; Chong IW; Lee LN
    Sci Rep; 2017 Nov; 7(1):16300. PubMed ID: 29176633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.
    Henkle E; Hedberg K; Schafer S; Novosad S; Winthrop KL
    Ann Am Thorac Soc; 2015 May; 12(5):642-7. PubMed ID: 25692495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in clinically significant nontuberculous Mycobacteria isolates at a Korean general hospital.
    Kim HS; Lee Y; Lee S; Kim YA; Sun YK
    Ann Lab Med; 2014 Jan; 34(1):56-9. PubMed ID: 24422197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.